Company news
Omeros Corporation news in 2020
Omeros Corporation's news releases, calls and decks from 2020, newest first.
CMS Confirms Continued Separate Payment for Omeros’ FDA-Approved OMIDRIA® in Ambulatory Surgery Centers
December 2, 2020
Omeros Submits its Biologics License Application to U.S. FDA for Narsoplimab in HSCT-TMA
November 17, 2020
Omeros Corporation Reports Third Quarter 2020 Financial Results
November 8, 2020
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2020
November 4, 2020
Omeros Reports Final Efficacy and Safety Data from the Narsoplimab Pivotal Trial in HSCT-TMA
October 21, 2020
Omeros Schedules Webcast to Present Final Efficacy Results from Narsoplimab BLA for the Treatment of HSCT-TMA
October 14, 2020
Omeros Provides Update on Separate Payment for OMIDRIA® in the ASCs
September 30, 2020
Omeros’ Investigational New Drug Application for OMS906 Cleared by FDA
August 30, 2020
Omeros Announces Pricing of Public Offerings
August 11, 2020
Omeros Corporation Reports Second Quarter 2020 Financial Results
August 9, 2020
Omeros Corporation Reports Recovery and Survival of All Patients in Study Evaluating Narsoplimab for Treatment of COVID-19-Associated Acute Respiratory Distress Syndrome
August 9, 2020
Omeros Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
August 9, 2020
Omeros Corporation Announces Presentation of Narsoplimab Pivotal Trial Data at Upcoming European Hematology Association Annual Congress
May 13, 2020
Omeros Corporation Reports First Quarter 2020 Financial Results
May 10, 2020
Omeros Corporation to Announce First Quarter Financial Results on May 11, 2020
May 4, 2020
Omeros Corporation Reports Updated Results from Narsoplimab HSCT-TMA Clinical Trial and Highlights from Recent Clinical and CMC Meetings with FDA
March 1, 2020
Omeros Corporation to Announce Fourth Quarter and Year-End 2019 Financial Results on March 2, 2020
February 23, 2020
Omeros Corporation Appoints Former Amazon Treasurer Kurt Zumwalt to Board of Directors
February 10, 2020